MCL1 and cancer: Our in vitro cell growth data showed that BM-1197 is about 8-times more effective than ABT-263 in MEF cells with Mcl-1 deletion and is 5-26-fold more potent than ABT-263 in 4 most sensitive SCLC cancer cell lines.